Breast conservation in breast cancer: Surgical and adjuvant considerations

Current Opinion in Obstetrics and Gynecology

Volumn 16, Issue 1, 2004, Pages 31-36

  Meric Bernstam, Funda ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast conservation; Breast conserving surgery; Local recurrence; Lumpectomy

Indexed keywords

ANTINEOPLASTIC AGENT;

BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FOLLOW UP; HUMAN; LONG TERM CARE; MASTECTOMY; MEDICAL EDUCATION; PHYSICIAN; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; PREOPERATIVE CARE; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 1342305491     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-200402000-00007     Document Type: Review

References (53)

1. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347:1227-1232. Landmark randomized prospective study comparing BCS plus breast irradiation with mastectomy.
2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347:1233-1241. Landmark randomized prospective study comparing BCS alone or BCS plus breast irradiation with mastectomy.
3. Arriagada R, Le MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 1996; 14:1558-1564.
4. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy. European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000; 92:1143-1150.
5. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003; 98:697-702.
6. Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 1992; 11:19-25.
7. Scarth H, Cantin J, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (summary of the 2002 update). CMAJ 2002; 167:154-155.
8. Morrow M, Strom EA, Bassett LW, et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin 2002; 52:277-300. Multidisciplinary guidelines for management of invasive breast cancer with BCS. The guidelines provide a framework for clinical decision making based on the published literature.
9. Staradub VL, Hsieh YC, Clauson J, et al. Factors that influence surgical choices in women with breast carcinoma. Cancer 2002; 95:1185-1190.
10. Prehn AW, Topol B, Stewart S, et al. Differences in treatment patterns for localized breast carcinoma among Asian/Pacific islander women. Cancer 2002; 95:2268-2275.
11. Hahn CA, Marks LB, Chen DY, et al. Breast conservation rates: barriers between tertiary care and community practice. Int J Radiat Oncol Biol Phys 2003; 55:1196-1199.
12. Paci E, Duffy SW, Giorgi D, et al. Are breast cancer screening programmes increasing rates of mastectomy? Observational study. BMJ 2002; 325:418.
13. Jakesz R, Samonigg H, Gnant M, et al. Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group. Ann Surg 2003; 237:556-564.
14. Keating NL, Weeks JC, Borbas C, Guadagnoli E. Treatment of early stage breast cancer: do surgeons and patients agree regarding whether treatment alternatives were discussed? Breast Cancer Res Treat 2003; 79:225-231.
15. Morrow M, White J, Moughan J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol 2001; 19:2254-2262.
16. Morrow M. Rational local therapy for breast cancer. N Engl J Med 2002; 347:1270-1271.
17. McKee MD, Cropp MD, Hyland A, et al. Provider case volume and outcome in the evaluation and treatment of patients with mammogram-detected breast carcinoma. Cancer 2002; 95:704-712.
18. Wolmark N, Wang J, Mamounas E, et al. Preoperative chemotherapy in patients wtth operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 2001; 30:96-102.
19. Cance WG, Carey LA, Calvo BF, et al. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. Ann Surg 2002; 236:295-302; discussion 302-303. Single institutional experience with BCS after preoperative chemotherapy for locally advanced breast cancer.
20. McIntosh SA, Ogston KN, Payne S, et al. Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy. Am J Surg 2003; 185:525-531.
21. Meric F, Mirza NQ, Vlastos G, et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 2003; 97:926-933.
22. Vicini FA, Kestin L, Huang R, Martinez A. Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy? Cancer 2003; 97:910-919.
23. Haffty BG, Reiss M, Beinfield M, et al. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol 1996; 14:52-57.
24. Elkhuizen PH, van de Vijver MJ, Hermans J, et al. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 1998; 40:859-867.
25. Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991; 338:327-331.
26. Huang E, Buchholz TA, Meric F, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 2002; 95:2059-2067. A single-institution retrospective study comparing the prognosis of true local recurrences with new primary cancers after breast conservation.
27. Liberman L, Morris EA, Dershaw DD, et al. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 2003; 180:901-910.
28. Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 2002; 184:383-393.
29. Swanson GP, Rynearson K, Symmonds R. Significance of margins of excision on breast cancer recurrence. Am J Clin Oncol 2002; 25:438-441.
30. Darvishian F, Hajdu SI, DeRisi DC. Significance of linear extent of breast carcinoma at surgical margin. Ann Surg Oncol 2003; 10:48-51.
31. Morrow M. Residual disease in DCIS: an excision too far? Cancer J 2003; 9:31-32.
32. Harris EE, Schultz DJ, Jones HA, Solin LJ. Factors associated with residual disease on re-excision in patients with ductal carcinoma in situ of the breast. Cancer J 2003; 9:42-48.
33. Rahusen FD, Bremers AJ, Fabry HF, et al. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol 2002; 9:994-998.
34. Israel P, Gittleman M, Fenoglio M, et al. A prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a new lesion localization device. Am J Surg 2002; 184:318-321.
35. Tafra L, Smith JS, Woodward JE, et al. Pilot study of cryo-assisted lumpectomy for small ultrasound visible breast cancers. In: Society of Surgical Oncology 56th Annual Cancer Symposium, Los Angeles, CA, 2003. Philadelphia, PA: Lippincott, Williams and Wilkins. p. S33.
36. Barros A, Pinotti M, Ricci MD, et al. Immediate effects of intraoperative evaluation of surgical margins over the treatment of early infiltrating breast carcinoma. Tumori 2003; 89:42-45.
37. Romestaing P, Lehingue Y, Carrie C, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997; 15:963-968.
38. Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 345:1378-1387.
39. Benda RK, Yasuda G, Sethi A, et al. Breast boost: are we missing the target? Cancer 2003; 97:905-909.
40. Graham P, Capp A, Fox C, et al. Why a breast boost should remain a controversial aspect of routine breast conservation management in Australia and New Zealand in 2002. Australas Radiol 2003; 47:44-49.
41. Fisher B, Dignam J, Bryant J, et al. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst 1996; 88:1529-1542.
42. Fisher B, Dignam J, Mamounas EP, et al. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. J Clin Oncol 1996; 14:1982-1992.
43. Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002; 20:4141-4149. Randomized prospective trial comparing the effect of tamoxifen alone, radiation alone and tamoxifen as well as radiation on IBTR rates after BCS.
44. Freedman GM, Hanlon AL, Fowble BL, et al. Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation. J Clin Oncol 2002; 20:4015-4021.
45. Van Limbergen E. Indications and technical aspects of brachytherapy in breast conserving treatment of breast cancer. Cancer Radiother 2003; 7:107-120.
46. Arthur DW, Koo D, Zwicker RD, et al. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys 2003; 56:681-689.
47. King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 2000; 180:299-304.
48. Vicini FA, Kestin L, Chen P, et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 2003; 95:1205-1210. Large matched-pair analysis of patients treated with brachytherapy versus whole-breast irradiation.
49. Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003; 55:289-293.
50. Baglan KL, Sharpe MB, Jaffray D, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys 2003; 55:302-311.
51. Komoike Y, Motomura K, Inaji H, et al. Repeat lumpectomy for patients with ipsilateral breast tumor recurrence after breast-conserving surgery: preliminary results. Oncology 2003; 64:1-6.
52. Resch A, Fellner C, Mock U, et al. Locally recurrent breast cancer pulse dose rate brachytherapy for repeat irradiation following lumpectomy: a second chance to preserve the breast. Radiology 2002; 225:713-718.
53. Dalberg K, Liedberg A, Johansson U, Rutqvist LE. Uncontrolled local disease after salvage treatment for ipsilateral breast tumour recurrence. Eur J Surg Oncol 2003; 29:143-154.